Optic pathway gliomas

Ben Shofty1, Liat Ben-Sira, Anat Kesler

  • 1Department of Pediatric Neurosurgery, Dana Children's Hospital, Tel-Aviv Medical Center, Tel Aviv University, 6th Weizmann St., Tel-Aviv, 64239, Israel.

Insights

Optic pathway gliomas (OPGs) are challenging pediatric brain tumors. Advances in imaging, surgery, and chemotherapy offer improved understanding and treatment outcomes for these challenging neoplasms.

Area of Science:

  • Pediatric Neuro-Oncology
  • Neoplasm Pathophysiology
  • Neuro-oncology Research

Background:

  • Optic pathway gliomas (OPGs) represent complex pediatric neoplasms.
  • Current understanding of OPG pathophysiology requires advancement.
  • Treatment outcomes for OPGs necessitate improvement.

Purpose of the Study:

  • To review recent technological advancements in OPG management.
  • To discuss the impact of new technologies on OPG pathophysiology understanding.
  • To outline current and emerging treatment paradigms for pediatric OPGs.

Main Methods:

  • Literature review of recent technological innovations.
  • Analysis of imaging, surgical, and chemotherapeutic advancements.
  • Synthesis of current treatment strategies for OPGs.

Main Results:

  • Technological progress in imaging enhances OPG detection and characterization.
  • Surgical techniques are evolving for improved OPG resection.
  • Chemotherapeutic regimens show promise for better clinical results in OPG treatment.

Conclusions:

  • Recent advancements significantly improve the understanding and management of pediatric optic pathway gliomas.
  • Integrated approaches utilizing novel imaging, surgical, and chemotherapeutic strategies are key.
  • Future research directions focus on refining treatment paradigms for better pediatric neuro-oncology outcomes.